Indaba Capital Management, L.P.

Q4 2024 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    10

  • Value ($000)

    $207,548

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001524362
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
OBDE
OBDE

BLUE OWL CAP CORP III

COM SHS
69122G102
$40.28M
19 %

2,793,366

---

BANDWIDTH INC

NOTE 0.500% 4/0
05988JAD5
$32.17M
16 %

40,250,000

ONTF
ONTF

ON24 INC

COM
68339B104
$27.39M
13 %

4,240,256

RVNC 1.75 02/15/27
RVNC 1.75 02/15/27

REVANCE THERAPEUTICS INC

NOTE 1.750% 2/1
761330AB5
$24.03M
12 %

25,000,000

INN 1.5 02/15/26
INN 1.5 02/15/26

SUMMIT HOTEL PPTYS

NOTE 1.500% 2/1
866082AA8
$21.97M
11 %

22,664,000

EQC
EQC

EQUITY COMWLTH

COM SH BEN INT
294628102
$16.90M
8 %

9,550,000

IRWD 1.5 06/15/26
IRWD 1.5 06/15/26

IRONWOOD PHARMACEUTICALS INC

NOTE 1.500% 6/1
46333XAH1
$13.04M
6 %

14,000,000

TVTX 2.5 09/15/25
TVTX 2.5 09/15/25

TRAVERE THERAPEUTICS INC

NOTE 2.500% 9/1
761299AB2
$12.83M
6 %

13,000,000

---

ACCELERATE DIAGNOSTICS INC

NOTE 5.000%12/1
00430HAC6
$12.34M
6 %

24,685,998

ESPR
ESPR

ESPERION THERAPEUTICS INC NE

COM
29664W105
$6.60M
3 %

3,000,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 10